Skip to content Skip to footer

Research Portal of the TU Dresden

The Lancet

ISSNs: 0140-6736

Additional searchable ISSN (electronic): 1474-547X

Elsevier Science B.V.

Scopus rating (2025): CiteScore 92.4 SJR 14.821 SNIP 27.703

Journal

Titles	The Lancet Lancet
Additional searchable titles	LANCET, Lancet (London, England), Lancet.
ISSNs	0140-6736
Additional searchable ISSN (electronic)	1474-547X
Publisher	Elsevier Science B.V.
ZDB-ID	3306-6
ZDB-ID	339572-8
ZDB-ID	1476593-7

Keywords

ASJC Scopus subject areas

Medicine (all)

Library keywords

610 Medicine and health

Related content

Research output

A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial

BigpAK-2 study group, Zarbock, A., Ostermann, M., Forni, L., Bode, C., Wild, L. & Putensen, C. & 33 others, Roux, D. P., Martín, E. E., Arndt, C., Rahmel, T., de Rosa, S., Monard, C., Schneider, A. G., Glass, A., Jung-König, M., Romagnoli, S., Gossage, J., Lumlertgul, N., Haaker, J. G., Ripollés-Melchor, J., Spadaro, S., Siniscalchi, A., Futier, E., Aupetitgendre, L., Bhathal, I. R., Álvarez, R. G., Bernard, A., Rosenberger, P., Wempe, C., Sadjadi, M., Meersch, M., Fischhuber, K., Bellomo, R., Kellum, J. A., von Groote, T., Güldner, A., Mirus, M., Spieth, P. M. & Shaw, D., 13 Dec 2025, In: The Lancet. 406, 10521, p. 2782-2791 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial

GPPAD-POInT Study Group, Nov 2025, In: The Lancet. 406, 10519, p. 2564-2576 13 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial

trial investigators, 10 May 2025, In: The Lancet. 405, 10490, p. 1676-1688 13 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial

PRESTIGE-AF Consortium, Veltkamp, R., Korompoki, E., Harvey, K. H., Harvey, E. R., Fießler, C. & Malzahn, U. & 44 others, Rücker, V., Montaner, J., Caso, V., Sibon, I., Ringleb, P., Halse, O., Hügen, K., Ullmann, S., Schuhmann, C., Todd, G. P., Haas, K., Palà, E., Debette, S., Lachaize, M., D'Aoust, T., Enzinger, C., Ropele, S., Fandler-Höfler, S., Haidegger, M., Wang, Y., Wafa, H. A., Cancelloni, V., Mosconi, M. G., Lip, G. Y. H., Lane, D. A., Haefeli, W. E., Foerster, K. I., Wurmbach, V. S., Nielsen, P. B., Hajjar, K., Müller, P., Poli, S., Purrucker, J., Laible, M., D'Anna, L., Silva, Y., de Torres Chacon, R., Martínez-Sánchez, P., Boulanger, M., Norrving, B., Paré, G., Wachter, R., Ntaios, G. & Wolfe, C. D. A., 15 Mar 2025, In: The Lancet. 405, 10482, p. 927-936 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

ESCAPE-NEXT Investigators, 15 Feb 2025, In: The Lancet. 405, 10478, p. 560-570 11 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (48)